Factors contributing to whether or not people with obesity undergo bariatric surgery

Obes Res Clin Pract. 2023 Nov-Dec;17(6):511-518. doi: 10.1016/j.orcp.2023.11.003. Epub 2023 Nov 24.

Abstract

Background: Bariatric surgery has been suggested as a safe and effective way to treat obesity by facilitating weight loss, but factors that predict the likelihood of bariatric surgery are unknown. The objective of this study was to describe factors associated with individuals with obesity that influence their decision to undergo bariatric surgery.

Subjects and methods: The study design was a cross-sectional study and participants were recruited via a survey link posted on the Obesity Action Coalition website. Demographic data, medical data, weight loss program data, and reports of personal experiences were gathered via an online survey. A multivariate logistic regression model was conducted to examine predictors associated with bariatric surgery (N = 4192).

Results: Participants who took phentermine (OR=2.983), Phentermine-topiramate (Qsymia) (OR=2.863), Naltrexone-bupropion (Contrave) (OR=3.246), or Liraglutide (Saxenda) (OR=2.144) had a higher likelihood of undergoing bariatric surgery for weight loss. Participants with type 2 diabetes (OR=1.728), post-traumatic stress disorder (PTSD) (OR=1.489), or COVID-19 (OR=3.852) had a higher likelihood of undergoing bariatric surgery while sleep apnea (OR=0.760) was associated with a lower likelihood of receiving surgery. Those who used MyFitnessPal™ (OR=2.232), Noom™ (OR=1.400), Jenny Craig™ (OR=1.533), or Keto (OR=1.664) for weight loss had a higher likelihood of obtaining bariatric surgery. Personal trauma experiences of sexual abuse (OR=1.982) and physical abuse (OR=1.490) were more associated with participants who underwent surgery.

Conclusions: A variety of characteristics were associated with decisions to undergo bariatric surgery. These findings may help to determine ways to support individuals who are considering bariatric surgery.

Keywords: Bariatric surgery; Obesity; Obesity-relate disorders.

MeSH terms

  • Anti-Obesity Agents*
  • Bariatric Surgery*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2*
  • Humans
  • Obesity / surgery
  • Obesity, Morbid* / surgery
  • Phentermine
  • Weight Loss

Substances

  • Anti-Obesity Agents
  • Phentermine